Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 34.3714.6689.44-31.9410.94

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 34.37 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202534.37
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2025 34.37
134.45
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹20,727.8 Cr -5.4% -9.5% 27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-5.4%

-9.5%

27.4%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses